SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-001592
Filing Date
2019-02-08
Accepted
2019-02-08 15:55:49
Documents
32
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 223451
2 ex31-1.htm EX-31.1 19646
3 ex31-2.htm EX-31.2 19673
4 ex32-1.htm EX-32.1 5584
5 ex32-2.htm EX-32.2 7329
  Complete submission text file 0001493152-19-001592.txt   935541

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE prtt-20170930.xml EX-101.INS 58840
7 XBRL SCHEMA FILE prtt-20170930.xsd EX-101.SCH 11116
8 XBRL CALCULATION FILE prtt-20170930_cal.xml EX-101.CAL 22322
9 XBRL DEFINITION FILE prtt-20170930_def.xml EX-101.DEF 27741
10 XBRL LABEL FILE prtt-20170930_lab.xml EX-101.LAB 93788
11 XBRL PRESENTATION FILE prtt-20170930_pre.xml EX-101.PRE 70126
Mailing Address 95 MERRICK WAY, THIRD FLOOR CORAL GABLES FL 33143
Business Address 95 MERRICK WAY, THIRD FLOOR CORAL GABLES FL 33143 954-866-3726
PROTECT PHARMACEUTICAL Corp (Filer) CIK: 0001493526 (see all company filings)

IRS No.: 271877179 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54001 | Film No.: 19579750
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1